Profile data is unavailable for this security.
About the company
Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases to include the additional contracted areas of sales, marketing and distribution of medical devices, medical testing and nutraceutical products. Its subsidiaries include BioClonetics lmmunotherapy, Inc. and Biogenysis, Inc.
- Revenue in USD (TTM)0.00
- Net income in USD-119.19k
- Incorporated2020
- Employees2.00
- LocationEnzolytics Inc2000 N Central Expy Ste 104PLANO 75074 -548United StatesUSA
- Phone+1 (626) 538-4779
- Fax+1 (845) 818-3588
- Websitehttps://enzolytics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purminds Enterprises Inc | 0.00 | -77.46k | 2.36m | 0.00 | -- | 0.0654 | -- | -- | -0.1832 | -0.1832 | 0.00 | 0.7646 | 0.00 | -- | -- | -- | -26.19 | -620.48 | -66.38 | -- | -- | -- | -- | -- | -- | -6.29 | 0.00 | -- | -- | -- | -13.29 | -- | -- | -- |
| Ernexa Therapeutics Inc | 1.00k | -18.36m | 2.39m | 6.00 | -- | 0.6708 | -- | 2,393.91 | -5.32 | -5.32 | 0.0002 | 0.4548 | 0.0001 | -- | 0.0059 | 166.67 | -264.07 | -187.10 | -2,044.59 | -237.72 | 100.00 | -- | -1,834,000.00 | -3,375.91 | -- | -2.73 | 0.00 | -- | 755.88 | -50.61 | -105.47 | -- | -19.54 | -- |
| Revelation Biosciences Inc | 0.00 | -14.08m | 2.44m | 8.00 | -- | 0.1255 | -- | -- | -120.02 | -120.02 | 0.00 | 12.27 | 0.00 | -- | -- | 0.00 | -82.96 | -- | -118.88 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12,406.06 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -3.95m | 2.44m | 2.00 | -- | 0.4058 | -- | -- | -7.30 | -7.30 | 0.00 | 3.35 | 0.00 | -- | -- | 0.00 | -75.76 | -86.22 | -80.46 | -561.06 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.15 | -- | -- | -- |
| Cardio Diagnostics Holdings Inc | 15.79k | -6.55m | 2.50m | 13.00 | -- | 0.2969 | -- | 158.44 | -4.07 | -4.07 | 0.0097 | 4.61 | 0.0024 | -- | 1.25 | 1,214.62 | -98.75 | -- | -104.31 | -- | -- | -- | -41,495.31 | -- | -- | -440.22 | 0.00 | -- | 104.39 | -- | -0.079 | -- | -- | -- |
| CNS Pharmaceuticals Inc | 0.00 | -13.07m | 2.54m | 4.00 | -- | 0.2371 | -- | -- | -130.83 | -130.83 | 0.00 | 17.25 | 0.00 | -- | -- | 0.00 | -135.60 | -153.00 | -197.11 | -237.57 | -- | -- | -- | -- | -- | -- | 0.0031 | -- | -- | -- | 21.18 | -- | -26.93 | -- |
| Propanc Biopharma Inc | 0.00 | -63.41m | 2.56m | 1.00 | -- | 0.1779 | -- | -- | -45.47 | -45.47 | 0.00 | 1.08 | 0.00 | -- | -- | 0.00 | -702.98 | -- | -1,223.40 | -- | -- | -- | -- | -- | -- | -56.99 | 0.0422 | -- | -- | -- | -2,826.43 | -- | -- | -- |
| Lyra Therapeutics Inc | 600.00k | -32.95m | 2.61m | 30.00 | -- | -- | -- | 4.35 | -23.78 | -23.78 | 0.418 | -2.63 | 0.0098 | -- | -- | 20,000.00 | -53.81 | -64.59 | -67.22 | -76.36 | -- | -- | -5,491.17 | -5,844.58 | -- | -- | -- | -- | -1.54 | -- | -49.07 | -- | 61.78 | -- |
| Enzolytics Inc | 0.00 | -119.19k | 2.66m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
| Hcw Biologics Inc | 422.03k | -22.21m | 2.73m | 36.00 | -- | -- | -- | 6.47 | -13.96 | -13.96 | 0.2716 | -0.8038 | 0.0162 | -- | 1.24 | 11,723.06 | -46.35 | -53.89 | -- | -66.10 | 20.00 | -- | -2,855.77 | -545.79 | -- | -42.26 | 1.45 | -- | -9.68 | -- | -20.12 | -- | -29.10 | -- |
| AIM ImmunoTech Inc | 112.00k | -15.75m | 2.79m | 21.00 | -- | -- | -- | 24.87 | -19.82 | -19.82 | 0.1067 | -2.20 | 0.0117 | -- | -- | 5,333.33 | -165.08 | -50.43 | -637.78 | -55.23 | 15.18 | -113.19 | -14,062.50 | -12,238.47 | -- | -- | -- | -- | -15.84 | 3.96 | 40.20 | -- | -45.22 | -- |
| InMed Pharmaceuticals Inc | 4.80m | -8.21m | 2.80m | 13.00 | -- | 0.2247 | -- | 0.5844 | -7.21 | -7.21 | 2.65 | 4.45 | 0.4028 | 3.01 | 15.28 | -- | -68.93 | -87.37 | -78.82 | -107.49 | 33.69 | -- | -171.13 | -356.16 | 6.37 | -27.94 | 0.00 | -- | 7.50 | -- | -6.34 | -- | -- | -- |
| Artelo Biosciences Inc | 0.00 | -12.49m | 2.91m | 5.00 | -- | -- | -- | -- | -20.88 | -20.88 | 0.00 | -0.407 | 0.00 | -- | -- | 0.00 | -219.08 | -- | -427.33 | -- | -- | -- | -- | -- | -- | -91.40 | 3.62 | -- | -- | -- | -5.78 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to Enzolytics Inc's reporting currency: US Dollar USD
0.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hilltop Partners LLCas of 30 Sep 2025 | 1.95m | 0.04% |
| Sandhill Capital Partners LLCas of 30 Sep 2025 | 100.00k | 0.00% |
| Vermillion & White Wealth Management Group LLCas of 30 Sep 2025 | 29.86k | 0.00% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
